{
    "organizations": [],
    "uuid": "1717eb5894a6231f1b93b5a1c246964ea5b4a31c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-seres-therapeutics-reports-qtrly-l/brief-seres-therapeutics-reports-qtrly-loss-per-share-of-0-69-idUSASC0A0W4",
    "ord_in_thread": 0,
    "title": "BRIEF-Seres Therapeutics Reports Qtrly Loss Per Share Of $0.69",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9, 2018 / 11:06 AM / in 9 minutes BRIEF-Seres Therapeutics Reports Qtrly Loss Per Share Of $0.69 Reuters Staff\nMay 9 (Reuters) - Seres Therapeutics Inc:\n* SERES THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATES\n* SERES THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.69\n* SERES THERAPEUTICS INC - QTRLY TOTAL REVENUE $4 MILLION VERSUS $3 MILLION Source text for Eikon: Further company coverage:",
    "published": "2018-05-09T14:05:00.000+03:00",
    "crawled": "2018-05-09T14:19:29.033+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "minute",
        "therapeutic",
        "report",
        "qtrly",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "seres",
        "therapeutic",
        "inc",
        "seres",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "operational",
        "update",
        "seres",
        "therapeutic",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "seres",
        "therapeutic",
        "inc",
        "qtrly",
        "total",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}